Home LiteratureArticle Details
PMID: 7216485 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Immune responses to labial infection of BALB/c mice with herpes simplex virus type 1.

Infection and immunity ·Vol. 32 ·No. 1 ·1981-04-00 ·Pages 180-7

Morahan PS, Thomson TA, Kohl S, Murray BK

Abstract

The kinetics of appearance of five humoral antibody responses (micro-neutralization assay [NT], complement fixation [CF], enzyme-linked immunosorbent assay [ELISA], radioimmunoassay [RIA], antibody-dependent cell-mediated cytotoxicity [ADCC]), were compared during labial infection of BALB/c mice with herpes simplex virus type 1 strain Patton. The ELISA/RIA antibody responses were present in most mice by day 5 after infection, at the beginning of the herpetic lip lesions; antibody effective in ADCC showed identical early kinetics. In contrast, NT/CF antibodies were not detected in most mice until day 10, at the time of resolution of the herpetic lip lesions. The humoral immune responses persisted for at least 6 months after infection. The NT and CF responses were closely correlated in time of appearance and titers (r = 0.9), as were the ELISA and RIA responses (r = 0.99). However, there was little correlation between NT/CF and ELISA/RIA responses (r = 0.02). The kinetics of the delayed type hypersensitivity response showed similar kinetics of appearance to the ELISA/RIA/ADCC humoral responses, and peaked similarly, but waned gradually over 2 months. The importance of antibody in protection against labial herpes simplex virus type 1 infection was demonstrated by the ability of passively transferred convalescent serum (that produced a minimum NT titer of 10 in recipient mice) to protect against development of herpetic lesions and death.

MeSH Terms
Animals Antibodies, Viral/biosynthesis Complement Fixation Tests Enzyme-Linked Immunosorbent Assay Herpes Simplex/microbiology Hypersensitivity, Delayed/immunology Immunization, Passive Kinetics Lip Diseases/etiology,microbiology Lymphocytes/immunology Male Mice Mice, Inbred BALB C Neutralization Tests Radioimmunoassay
Chemicals
Antibodies, Viral
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Morahan P S
Thomson T A
Kohl S
Murray B K
References (25)
25 references, click to expand
  1. Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells.
    J Infect Dis. 1973 Jun;127(6):632-8 PMID: 4350518
  2. Cellular immunity to herpes simplex virus mediated by interferon.
    J Exp Med. 1974 Sep 1;140(3):764-78 PMID: 4369835
  3. Maintenance of latent herpetic infection: an apparent role for anti-viral IgG.
    J Immunol. 1974 Dec;113(6):1685-93 PMID: 4372269
  4. Latent infection of sensory ganglia with herpes simplex virus: efficacy of immunization.
    Science. 1975 May 30;188(4191):938-40 PMID: 166432
  5. Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection.
    Infect Immun. 1975 Jul;12(1):166-72 PMID: 166926
  6. Immunological basis for latency, recurrences and putative oncogenicity of herpes simplex virus.
    Lancet. 1975 Jul 12;2(7924):60-2 PMID: 49654
  7. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
    J Immunol. 1976 Jan;116(1):35-40 PMID: 173758
  8. The role of antibody dependent cytotoxicity in recovery from herpesvirus infections.
    Cell Immunol. 1976 Mar 1;22(1):182-6 PMID: 179716
  9. Immunological response restricts number of cells in sensory ganglia infected with herpes simplex virus.
    Nature. 1976 Dec 9;264(5586):554-6 PMID: 1004594
  10. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
    J Immunol. 1977 Feb;118(2):567-73 PMID: 65428
  11. Pathogenesis of latent herpes simplex virus infection of the trigeminal ganglion in guinea pigs: effects of age, passive immunization, and hydrocortisone.
    Infect Immun. 1977 Apr;16(1):69-74 PMID: 301508
  12. Protection from oral herpes simplex virus infection by a nucleic acid-free virus vaccine.
    Infect Immun. 1977 Jun;16(3):955-60 PMID: 197013
  13. Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2.
    J Immunol. 1977 Dec;119(6):2030-6 PMID: 72115
  14. Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection.
    Infect Immun. 1978 Aug;21(2):489-95 PMID: 689732
  15. Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread.
    Infect Immun. 1979 Feb;23(2):305-11 PMID: 217828
  16. Route of infection, systemic host resistance, and integrity of ganglionic axons influence acute and latent herpes simplex virus infection of the superior cervical ganglion.
    Infect Immun. 1979 Feb;23(2):373-83 PMID: 422245
  17. Murine antibody-dependent cellular cytotoxicity to herpes simplex virus-infected target cells.
    J Immunol. 1979 Jul;123(1):25-30 PMID: 448149
  18. Immune control of herpesvirus latency.
    Can J Microbiol. 1979 Mar;25(3):267-74 PMID: 222416
  19. Effect of pyran on latency after herpes simplex virus infections.
    Antimicrob Agents Chemother. 1979 Apr;15(4):547-53 PMID: 464586
  20. Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody.
    J Infect Dis. 1979 Oct;140(4):534-40 PMID: 229174
  21. The role of natural killer cells and antibody-dependent cell-mediated cytotoxicity during murine cytomegalovirus infection.
    J Exp Med. 1979 Dec 1;150(6):1549-54 PMID: 229190
  22. Acylovir in oral and ganglionic herpes simplex virus infections.
    J Infect Dis. 1979 Nov;140(5):802-6 PMID: 316819
  23. Serum antibodies to herpes simplex virus type 1 during active oral herpes infection.
    Infect Immun. 1980 Jan;27(1):113-7 PMID: 6244224
  24. Topical therapeutic efficacy of 9-(2-hydroxyethoxymethyl)guanine and 5-iodo-5'-amino-2',5'-dideoxyuridine on oral infection with herpes simplex virus in mice.
    J Infect Dis. 1980 May;141(5):575-9 PMID: 6966305
  25. MHC matching shows that at least two T-cell subsets determine resistance to HSV.
    Nature. 1979 Jan 4;277(5691):66-8 PMID: 233263
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1981-04-00
Pages
180-7
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC350604
Subset
IM
Grants
PHS HHS · 1 PO 1H01 3021 · United States
NCI NIH HHS · CA 24686 · United States
NIDCR NIH HHS · DE 04700 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]